Literature DB >> 13523400

Splenectomy in blood dyscrasia.

M M WOOLLEY, E J JOERGENSON.   

Abstract

THE DECISION FOR SPLENECTOMY MUST BE BASED ON A KNOWLEDGE OF THE THREE FUNCTIONS OF THE SPLEEN: Hematopoiesis (usually ceasing during fetal life but sometimes resuming when bone marrow function fails); filtration of abnormal and senescent cells and control of bone marrow activity, most probably humoral. When bone marrow function fails, splenectomy is contraindicated since splenic hematopoiesis becomes a vital function. On the other hand, when a large proportion of erythrocytes are abnormally shaped (spherocytes), although otherwise adequate, the spleen may trap these cells in its filter and destroy large numbers. Splenectomy is beneficial in almost every case of congenital spherocytosis, but in only half the cases of the acquired defect. In panhematocytopenia, thrombocytopenia and neutropenia, all apparently due to depression of hematopoiesis by endocrine or other action of the spleen, splenectomy may be beneficial if medical therapy fails.A SURGEON UNDERTAKING SPLENECTOMY SHOULD RECOGNIZE TWO SPECIAL PROBLEMS: (1) The presence of accessory spleens, which if not removed may negate the effects of the operation, and (2) the apparently high rate of infection in infants and children who have undergone splenectomy.

Entities:  

Keywords:  BLOOD DISEASES/surgery; SPLEEN/surgery

Mesh:

Substances:

Year:  1958        PMID: 13523400      PMCID: PMC1512215     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  14 in total

1.  Indications for splenectomy.

Authors:  J E OREBAUGH; F A COLLER
Journal:  Surgery       Date:  1955-05       Impact factor: 3.982

2.  The thrombocytopenic purpuras.

Authors:  E L LOZNER
Journal:  Bull N Y Acad Med       Date:  1954-03

3.  Bone marrow in idiopathic thrombocytopenic purpura; analysis of 100 cases with reference to the prognostic significance of eosinophils and megakaryocytes.

Authors:  S J PRESLEY; W R BEST; L R LIMARZI
Journal:  J Lab Clin Med       Date:  1952-10

4.  Differential diagnosis, pathogenesis and treatment of the thrombocytopenic purpuras.

Authors:  E L LOZNER
Journal:  Am J Med       Date:  1953-04       Impact factor: 4.965

5.  The practice and consequences of splenectomy.

Authors:  H C EDWARDS
Journal:  Lancet       Date:  1951-10-06       Impact factor: 79.321

6.  The Surgical Significance of the Accessory Spleen.

Authors:  G M Curtis; D Movitz
Journal:  Ann Surg       Date:  1946-02       Impact factor: 12.969

7.  Effect of corticotrophin on chronic, severe primary thrombocytopenic purpura.

Authors:  R S EVANS; C K LIU
Journal:  AMA Arch Intern Med       Date:  1951-10

8.  Hereditary spherocytosis. II. Observations on the role of the spleen.

Authors:  L E YOUNG; R F PLATZER; D M ERVIN; M J IZZO
Journal:  Blood       Date:  1951-11       Impact factor: 22.113

9.  The treatment of acquired hemolytic anemia. With a note on the relationship of periarteritis nodosa to hemolytic anemia.

Authors:  W DAMESHEK; M C ROSENTHAL
Journal:  Med Clin North Am       Date:  1951-09       Impact factor: 5.456

10.  Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy.

Authors:  H KING; H B SHUMACKER
Journal:  Ann Surg       Date:  1952-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.